Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Breast Cancer Research and Treatment
|
February 16, 2021
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
Andrew Wardley, Javier Cortes, Louise Provencher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II study
Lorenzo Gerratana, Carolina Reduzzi, Yue Ren, et al.
American Heart Journal
|
June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Roberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Mabs
|
March 2, 2010
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2
Roni Mamluk, Irvith M Carvajal, Brent A Morse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2018
Preclinical Antitumor Activity of a Novel Anti-c-KIT Antibody-Drug Conjugate against Mutant and Wild-type c-KIT-Positive Solid Tumors
Tinya Abrams, Anu Connor, Christie Fanton, et al.
Molecular Cancer Therapeutics
|
April 21, 2021
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies
Qing Sheng, Joseph A D'Alessio, Daniel L Menezes, et al.
The New England Journal of Medicine
|
January 28, 2026
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer
Otto Metzger, Sumithra Mandrekar, Shom Goel, et al.
JACC. Cardiooncology
|
January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial
Roberto Bolli, Emerson C Perin, James T Willerson, et al.
Nature
|
December 11, 2012
Seventy-five genetic loci influencing the human red blood cell
Pim van der Harst, Weihua Zhang, Irene Mateo Leach, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Breast Cancer Research and Treatment
|
February 16, 2021
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
Andrew Wardley, Javier Cortes, Louise Provencher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II study
Lorenzo Gerratana, Carolina Reduzzi, Yue Ren, et al.
American Heart Journal
|
June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Roberto Bolli, Joshua M Hare, Timothy D Henry, et al.
Mabs
|
March 2, 2010
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2
Roni Mamluk, Irvith M Carvajal, Brent A Morse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2018
Preclinical Antitumor Activity of a Novel Anti-c-KIT Antibody-Drug Conjugate against Mutant and Wild-type c-KIT-Positive Solid Tumors
Tinya Abrams, Anu Connor, Christie Fanton, et al.
Molecular Cancer Therapeutics
|
April 21, 2021
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing Malignancies
Qing Sheng, Joseph A D'Alessio, Daniel L Menezes, et al.
The New England Journal of Medicine
|
January 28, 2026
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer
Otto Metzger, Sumithra Mandrekar, Shom Goel, et al.
JACC. Cardiooncology
|
January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial
Roberto Bolli, Emerson C Perin, James T Willerson, et al.
Nature
|
December 11, 2012
Seventy-five genetic loci influencing the human red blood cell
Pim van der Harst, Weihua Zhang, Irene Mateo Leach, et al.
Page
of 5